Abstract
The developing fertility preservation technologies offer new options, but not without a cost. As the technologies become integrated into the healthcare marketplace, cost will become an even greater issue. A critical question in this discussion is whether young women and their parents would be willing to pay for insurance to cover the cost of these procedures.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
The term oncofertility was coined by Dr. Teresa Woodruff at Northwestern University’s Feinberg School of Medicine.
- 2.
In embryo banking, the harvested eggs are fertilized with a partner’s or donor’s sperm and the resulting embryo is frozen for later use with IVF.
- 3.
Though removal of ovarian tissue is an established procedure, the techniques for freezing and thawing the tissue and use of the thawed tissue in “in follicle maturation” (IFM) are still experimental and this procedure has not yet resulted in pregnancy in humans. (http://www.myoncofertility.org/articles/what_oncofertility_consortiums_current_project)
- 4.
Individuals whose WTP for OC equals or exceeds $30,000 should be willing to pay at least $300 for insurance, which is the actuarially fair value. Those who value OC at less than $30,000 might prefer not to purchase insurance at $300 unless they are very risk averse.
References
Neumann PJ, Johannesson MThe Willingness-to-pay for in vitro Fertilization: a pilot study using contingent Valuation. Med Care. 1994; 32(7):686–99.
Ryan M. Using conjoint analysis to take account of patient preferences and go beyond health outcomes: an application to in vitro fertilisation. Soc Sci Med. 1999; 48(4):535–46.
Olsen JA, Smith RD. Theory versus practice: a review of ‘willingness-to-pay’ in health and health care. Health Econ. 2001; 10(1):39–52.
Kenkel D, Berger M, Blomquist G Contingent valuation of health. In: Tolley G, Kenkel D, Fabian R, Eds. Valuing health for policy. Chicago: University of Chicago Press; 1994:72–104.
Becker G. et al. Value of Life Near Its End and Terminal Care. NBER Working Paper 13333; 2007. Available at http://www.nber.org/papers/w13333. Accessed October 20, 2009.
Acknowledgments
This research was supported by the Oncofertility Consortium NIH 8UL1DE019587, 5RL1HD058296.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Gardino, S.L., Sfekas, A., Dranove, D. (2010). Anticipating Ovarian Tissue Cryopreservation in the Health-Care Marketplace: A Willingness to Pay Assessment. In: Woodruff, T., Zoloth, L., Campo-Engelstein, L., Rodriguez, S. (eds) Oncofertility. Cancer Treatment and Research, vol 156. Springer, Boston, MA. https://doi.org/10.1007/978-1-4419-6518-9_27
Download citation
DOI: https://doi.org/10.1007/978-1-4419-6518-9_27
Published:
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4419-6517-2
Online ISBN: 978-1-4419-6518-9
eBook Packages: MedicineMedicine (R0)